نتایج جستجو برای: radiosensitizer

تعداد نتایج: 575  

Journal: :Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2015
Ly-Binh-An Tran Anne Bol Daniel Labar Thanh-Trang Cao-Pham Bénédicte Jordan Vincent Grégoire Bernard Gallez

PURPOSE To assess the predictive value of hypoxia imaging by (18)F-FAZA PET in identifying tumors that may benefit from radiotherapy combined with nimorazole, a hypoxic radiosensitizer. MATERIAL AND METHODS Rats of two tumor models (Rhabdomyosarcoma and 9L-glioma) were divided into two treated groups: radiotherapy (RT) alone or RT plus nimorazole. (18)F-FAZA PET images were obtained to evalua...

Journal: :Acta biochimica Polonica 2004
Alberto Colasanti Annamaria Kisslinger Maria Quarto Patrizia Riccio

Human prostate cancer cells were evaluated for growth after photodynamic therapy, radiotherapy, and combined treatment. Indocyanine green was tested as a photosensitizer and radiosensitizer. Two human cell lines were used: PC-3 derived from prostate carcinoma, and EPN derived from normal prostate tissue. The light source used for the photoactivation experiments was a diode laser peaked at 805 n...

Journal: :Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2008
Joelle Haykal Pamela Fernainy Wafica Itani Makhluf Haddadin Fady Geara Colin Smith Hala Gali-Muhtasib

BACKGROUND AND PURPOSE Previously, we have reported that 2-benzoyl-3-phenyl-6,7-dichloroquinoxaline 1,4-dioxide (DCQ) is a radiosensitizer. Here, we investigate the mechanism of radiosensitization. MATERIALS AND METHODS EMT6 cells were treated with DCQ for 4h prior to ionizing radiation (IR). Flow cytometry, clonogenic assay, TUNEL, and Western blotting were performed to assess the effect of ...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2009
J Sigmond R J Honeywell T J Postma C M F Dirven S M de Lange K van der Born A C Laan J C A Baayen C J Van Groeningen A M Bergman G Giaccone G J Peters

Glioblastoma multiforme (GBM), the most frequent malignant brain tumor, has a poor prognosis, but is relatively sensitive to radiation. Both gemcitabine and its metabolite difluorodeoxyuridine (dFdU) are potent radiosensitizers. The aim of this phase 0 study was to investigate whether gemcitabine passes the blood-tumor barrier, and is phosphorylated in the tumor by deoxycytidine kinase (dCK) to...

2017
Eun Ho Kim Mi-Sook Kim Hyo Sook Song Seung Hoon Yoo Sei Sai Kwangzoo Chung Jiwon Sung Youn Kyoung Jeong YunHui Jo Myonggeun Yoon

The purpose of this study was to investigate the potential of gold nanoparticles as radiosensitizer for use in neutron therapy against hepatocellular carcinoma. The hepatocellular carcinoma cells lines Huh7 and HepG2 were irradiated with γ and neutron radiation in the presence or absence of gold nanoparticles. Effects were evaluated by transmission electron microscopy, cell survival, cell cycle...

Journal: :Oncology reports 2013
Yasushi Sawai Hiroaki Murata Motoyuki Horii Kazutaka Koto Takaaki Matsui Naoyuki Horie Yoshiro Tsuji Eishi Ashihara Taira Maekawa Toshikazu Kubo Shinji Fushiki

Sulforaphane (SFN), a naturally occurring member of the isothiocyanate family, is effective against various types of malignant tumor cells. We studied whether the combination of SFN and radiation would be more effective against osteosarcoma cells when compared to these treatments alone. LM8 murine osteosarcoma cells were cultured with various conc...

Journal: :Cancer research 2015
Lisa Buckel Elamprakash N Savariar Jessica L Crisp Karra A Jones Angel M Hicks Daniel J Scanderbeg Quyen T Nguyen Jason K Sicklick Andrew M Lowy Roger Y Tsien Sunil J Advani

Intrinsic tumor resistance to radiotherapy limits the efficacy of ionizing radiation (IR). Sensitizing cancer cells specifically to IR would improve tumor control and decrease normal tissue toxicity. The development of tumor-targeting technologies allows for developing potent radiosensitizing drugs. We hypothesized that the anti-tubulin agent monomethyl auristatin E (MMAE), a component of a cli...

2014
Fang-bo Cui Qin Liu Ru-Tian Li Jie Shen Pu-yuan Wu Li-Xia Yu Wen-jing Hu Feng-lei Wu Chun-Ping Jiang Guo-feng Yue Xiao-Ping Qian Xi-Qun Jiang Bao-Rui Liu

Radiotherapy is the main locoregional control modality for many types of unresectable tumors, including gastric cancer. However, many patients fail radiotherapy due to intrinsic radioresistance of cancer cells, which has been found to be strongly associated with cancer stem cell (CSC)-like properties. In this study, we developed a nanoparticle formulation to deliver miR-200c, which is reported ...

2015
Xiao-Dong Zhang Zhentao Luo Jie Chen Shasha Song Xun Yuan Xiu Shen Hao Wang Yuanming Sun Kai Gao Lianfeng Zhang Saijun Fan David Tai Leong Meili Guo Jianping Xie

Radiotherapy is often the most straightforward first line cancer treatment for solid tumors. While it is highly effective against tumors, there is also collateral damage to healthy proximal tissues especially with high doses. The use of radiosensitizers is an effective way to boost the killing efficacy of radiotherapy against the tumor while drastically limiting the received dose and reducing t...

Journal: :Molecular cancer therapeutics 2006
Carolyn Cao Eric T Shinohara Ty K Subhawong Ling Geng Kwang Woon Kim Jeffrey M Albert Dennis E Hallahan Bo Lu

p53 plays a critical role in cell cycle arrest and induction of apoptosis. Certain malignancies carry wild-type p53, which is frequently down-regulated by murine double minute 2 (MDM2) overexpression. Availability of a small-molecule inhibitor against MDM2, nutlin, has made it feasible to evaluate the anti-MDM2-based therapeutic strategies. The rationale for the current study is that functional...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید